Average 126% gains – NO losers!?

From Weiss Ratings | Ad

An epic crash is all but inevitable, but these dark times can offer staggering opportunities.

Today, Dr. Martin Weiss reveals "Crash Profit Trades" that could have produced average gains of 126% even when stocks tumbled.

All with NO losing trades!

Click Here to Discover the Secret.

>>>

PMVP Insider Trading (PMV Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $16,769,842.52

PMV Pharmaceuticals Insider Trading History Chart

PMV Pharmaceuticals Share Price & Price History

^$17.17

▲ +1.43 (9.09%)

As of 08/10/2022 04:59 PM ET

Days: 30 | 90 | 365

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

PMV Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/26/2022	Orbimed Advisors Llc	Major Shareholder	Sell	26,253	$15.93	$418,210.29	87,786
3/31/2022	Orbimed Advisors Llc	Major Shareholder	Sell	34,500	$21.17	$730,365.00
3/29/2022	Orbimed Advisors Llc	Major Shareholder	Sell	365,000	$21.52	$7,854,800.00
10/6/2021	Thilo Schroeder	Director	Sell	800	$30.15	$24,120.00
10/4/2021	Thilo Schroeder	Director	Sell	100	$30.08	$3,008.00
10/1/2021	Thilo Schroeder	Director	Sell	11,541	$30.10	$347,384.10
9/29/2021	Thilo Schroeder	Director	Sell	5,708	$30.04	$171,468.32
9/27/2021	Thilo Schroeder	Director	Sell	1,753	$30.11	$52,782.83
9/22/2021	Arnold J. Levine	Director	Sell	3,500	$30.00	$105,000.00
9/17/2021	Thilo Schroeder	Director	Sell	711	$30.03	$21,351.33
9/13/2021	Thilo Schroeder	Director	Sell	13,272	$30.20	$400,814.40
9/9/2021	Thilo Schroeder	Director	Sell	14,329	$30.31	$434,311.99
9/7/2021	Leila Alland	Insider	Sell	3,900	$30.25	$117,975.00
9/1/2021	Thilo Schroeder	Director	Sell	21,986	$30.38	$667,934.68
8/30/2021	Thilo Schroeder	Director	Sell	13,233	$30.05	$397,651.65
8/27/2021	Thilo Schroeder	Director	Sell	24,442	$30.52	$745,969.84
8/25/2021	Thilo Schroeder	Director	Sell	13,526	$31.01	$419,441.26
8/23/2021	Arnold J. Levine	Director	Sell	3,500	$29.50	$103,250.00	413,342
8/18/2021	Thilo Schroeder	Director	Sell	26,864	$33.34	$895,645.76
8/16/2021	Thilo Schroeder	Director	Sell	22,183	$33.89	$751,781.87
8/13/2021	Thilo Schroeder	Director	Sell	27,286	$34.24	$934,272.64
8/11/2021	Thilo Schroeder	Director	Sell	34,439	$34.04	$1,172,303.56
8/9/2021	Leila Alland	Insider	Sell	4,471	$34.04	$152,192.84
8/9/2021	Thilo Schroeder	Director	Sell	22,182	$35.53	$788,126.46
8/6/2021	Thilo Schroeder	Director	Sell	19,900	$36.61	$728,539.00
8/4/2021	Thilo Schroeder	Director	Sell	52,860	$35.85	$1,895,031.00
8/3/2021	Winston Kung	CFO	Sell	4,500	$33.82	$152,190.00	6,100
8/2/2021	Thilo Schroeder	Director	Sell	13,031	$34.74	$452,696.94
7/28/2021	Thilo Schroeder	Director	Sell	8,724	$35.76	$311,970.24
7/26/2021	Thilo Schroeder	Director	Sell	4,839	$35.73	$172,897.47
7/22/2021	Thilo Schroeder	Director	Sell	200	$35.61	$7,122.00
7/20/2021	Arnold J. Levine	Director	Sell	3,500	$35.12	$122,920.00
7/20/2021	David Henry Mack	CEO	Sell	1,029	$35.53	$36,560.37
7/8/2021	Winston Kung	CFO	Sell	4,500	$33.75	$151,875.00
7/7/2021	Leila Alland	Insider	Sell	4,000	$32.30	$129,200.00
6/28/2021	David Henry Mack	CEO	Sell	204	$35.53	$7,248.12	12,674
6/21/2021	Arnold J. Levine	Director	Sell	3,500	$33.25	$116,375.00	420,453
6/14/2021	Euclidean Capital Llc	Major Shareholder	Sell	44,419	$34.11	$1,515,132.09
6/11/2021	Euclidean Capital Llc	Major Shareholder	Sell	21,977	$33.80	$742,822.60
6/9/2021	Euclidean Capital Llc	Major Shareholder	Sell	39,638	$33.64	$1,333,422.32
6/7/2021	Euclidean Capital Llc	Major Shareholder	Sell	30,721	$33.62	$1,032,840.02
6/7/2021	Leila Alland	Insider	Sell	4,000	$33.60	$134,400.00	4,000
6/4/2021	Winston Kung	CFO	Sell	4,500	$33.75	$151,875.00	6,100
6/1/2021	Richard A. Heyman	Director	Sell	3,900	$32.55	$126,945.00
5/28/2021	Thilo Schroeder	Director	Sell	5,100	$35.80	$182,580.00
5/26/2021	Thilo Schroeder	Director	Sell	7,487	$35.66	$266,986.42
5/24/2021	Thilo Schroeder	Director	Sell	22,095	$36.03	$796,082.85
5/21/2021	David Henry Mack	CEO	Sell	6,207	$35.71	$221,651.97	10,263
5/20/2021	Arnold J. Levine	Director	Sell	3,500	$34.51	$120,785.00	426,803
5/10/2021	Thilo Schroeder	Director	Sell	1,787	$35.67	$63,742.29
5/7/2021	Leila Alland	Insider	Sell	4,000	$34.83	$139,320.00	4,000
5/5/2021	Thilo Schroeder	Director	Sell	600	$35.64	$21,384.00
5/3/2021	Winston Kung	CFO	Sell	4,500	$33.75	$151,875.00	6,100
4/12/2021	Thilo Schroeder	Director	Sell	3,903	$31.41	$122,593.23
4/8/2021	Thilo Schroeder	Director	Sell	136,436	$34.31	$4,681,119.16
4/7/2021	Leila Alland	Insider	Sell	4,000	$33.86	$135,440.00	4,000
4/5/2021	Thilo Schroeder	Director	Sell	48,193	$33.81	$1,629,405.33
3/31/2021	Thilo Schroeder	Director	Sell	33,626	$32.52	$1,093,517.52
3/29/2021	Thilo Schroeder	Director	Sell	2,174	$32.15	$69,894.10
3/26/2021	Thilo Schroeder	Director	Sell	35,268	$33.44	$1,179,361.92
3/24/2021	Thilo Schroeder	Director	Sell	34,881	$36.50	$1,273,156.50
9/29/2020	Ra Capital Management, L.P.	Major Shareholder	Buy	950,000	$18.00	$17,100,000.00

Is Apple Pointing to a Massive Recession in the U.S.?

From Chaikin Analytics | Ad

Apple (AAPL) is making moves behind the scenes to prepare for a downturn…Bloomberg recently reported that the tech giant plans to freeze hiring in some divisions- while remaining cautious on spending through next year. And the thing is, Apple isn’t alone…Bottom-line: Apple might be pointing to a massive recession in the U.S. If you have any serious assets in the market, there is one critical step you must take now.

Click for THE one critical step you must take now.

SEC Filings (Institutional Ownership Changes) for PMV Pharmaceuticals (NASDAQ:PMVP)

Institutional Buying and Selling by Quarter

PMV Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/9/2022	Swiss National Bank	48,200	$0.69M	0.0%	+79.9%	0.106%
8/5/2022	M&T Bank Corp	34,914	$0.50M	0.0%	+256.9%	0.077%
8/5/2022	Personal CFO Solutions LLC	550,342	$7.84M	1.8%	+57.1%	1.208%
8/5/2022	Los Angeles Capital Management LLC	31,470	$0.45M	0.0%	+61.8%	0.069%
8/4/2022	Evoke Wealth LLC	133,122	$1.90M	0.1%	+317.1%	0.292%
8/2/2022	Interwest Venture Management Co.	1,614,911	$23.01M	42.8%	-50.1%	3.544%
7/29/2022	SG Americas Securities LLC	64,830	$0.92M	0.0%	N/A	0.142%
7/29/2022	Russell Investments Group Ltd.	2,141	$30K	0.0%	N/A	0.005%
7/27/2022	Assenagon Asset Management S.A.	629,539	$8.97M	0.0%	-1.3%	1.381%
6/30/2022	Amalgamated Bank	4,271	$89K	0.0%	N/A	0.009%
6/7/2022	Bank of America Corp DE	256,837	$5.35M	0.0%	+247.9%	0.564%
5/17/2022	Royal Bank of Canada	1,611	$34K	0.0%	-73.2%	0.004%
5/17/2022	RTW Investments LP	3,872,154	$80.62M	1.7%	+29.9%	8.497%
5/16/2022	California State Teachers Retirement System	20,847	$0.43M	0.0%	-12.1%	0.046%
5/16/2022	Goldman Sachs Group Inc.	418,045	$8.70M	0.0%	+67.7%	0.918%
5/16/2022	Viking Global Investors LP	1,076,000	$22.40M	0.1%	-39.9%	2.363%
5/16/2022	Woodline Partners LP	718,093	$14.95M	0.2%	+140.5%	1.577%
5/16/2022	Wellington Management Group LLP	64,456	$1.34M	0.0%	+105.7%	0.142%
5/16/2022	State Street Corp	2,565,545	$53.42M	0.0%	+53.0%	5.635%
5/16/2022	UBS Group AG	189,011	$3.94M	0.0%	+46.6%	0.415%
5/13/2022	Northern Trust Corp	245,758	$5.12M	0.0%	-1.4%	0.540%
5/13/2022	Charles Schwab Investment Management Inc.	194,876	$4.06M	0.0%	+2.7%	0.428%
5/13/2022	Federated Hermes Inc.	381,976	$7.95M	0.0%	+22.4%	0.839%
5/13/2022	American International Group Inc.	13,023	$0.27M	0.0%	-6.6%	0.029%
5/13/2022	Vanguard Group Inc.	2,738,883	$57.02M	0.0%	+3.4%	6.016%
5/12/2022	Integral Health Asset Management LLC	50,000	$1.04M	0.3%	N/A	0.110%
5/12/2022	BlackRock Inc.	2,640,350	$54.97M	0.0%	+4.0%	5.799%
5/12/2022	Rhumbline Advisers	27,690	$0.58M	0.0%	+7.7%	0.061%
5/12/2022	Metropolitan Life Insurance Co NY	1,917	$40K	0.0%	-76.4%	0.004%
5/12/2022	MetLife Investment Management LLC	16,818	$0.35M	0.0%	+58.5%	0.037%
5/12/2022	Healthcare of Ontario Pension Plan Trust Fund	781,600	$16.27M	0.1%	N/A	1.717%
5/12/2022	Citigroup Inc.	27,974	$0.58M	0.0%	-71.7%	0.061%
5/12/2022	Blueshift Asset Management LLC	13,635	$0.28M	0.0%	N/A	0.030%
5/11/2022	US Bancorp DE	2,016	$42K	0.0%	+2,588.0%	0.004%
5/11/2022	JPMorgan Chase & Co.	3,205,487	$66.74M	0.0%	+1.2%	7.040%
5/11/2022	Jennison Associates LLC	303,641	$6.32M	0.0%	-41.0%	0.667%
5/10/2022	ProShare Advisors LLC	9,614	$0.20M	0.0%	-20.7%	0.021%
5/9/2022	Principal Financial Group Inc.	618,926	$12.89M	0.0%	+3.7%	1.359%
5/9/2022	Swiss National Bank	26,800	$0.56M	0.0%	+8.5%	0.059%
5/6/2022	Los Angeles Capital Management LLC	19,450	$0.41M	0.0%	+55.0%	0.043%
5/4/2022	Victory Capital Management Inc.	50,510	$1.05M	0.0%	-95.1%	0.111%
5/2/2022	Personal CFO Solutions LLC	350,342	$7.29M	1.4%	-36.3%	0.769%
4/29/2022	Nisa Investment Advisors LLC	1,200	$25K	0.0%	N/A	0.003%
4/28/2022	DekaBank Deutsche Girozentrale	17,600	$0.38M	0.0%	+10.0%	0.039%
4/25/2022	Assenagon Asset Management S.A.	638,064	$13.28M	0.0%	+507.2%	1.404%
2/19/2022	Woodline Partners LP	298,610	$6.90M	0.1%	-26.7%	0.658%
2/14/2022	Virtus ETF Advisers LLC	7,151	$0.17M	0.1%	+14.8%	0.016%
2/14/2022	Deerfield Management Company L.P. Series C	522,000	$12.06M	0.3%	-35.1%	1.150%
2/14/2022	Boxer Capital LLC	2,838,236	$65.56M	2.5%	+25.1%	6.254%
2/14/2022	Perceptive Advisors LLC	125,000	$2.89M	0.0%	-58.6%	0.275%
2/14/2022	Point72 Hong Kong Ltd	3,785	$87K	0.0%	N/A	0.008%
2/14/2022	Nextech Invest AG	1,385,807	$32.01M	7.4%	N/A	3.054%
2/14/2022	HarbourVest Partners LLC	11,533	$0.27M	0.0%	+49.9%	0.025%
2/10/2022	JPMorgan Chase & Co.	3,167,222	$73.16M	0.0%	+75.3%	6.979%
2/10/2022	Qube Research & Technologies Ltd	18,168	$0.42M	0.0%	N/A	0.040%
2/10/2022	Rafferty Asset Management LLC	118,194	$2.73M	0.0%	+48.8%	0.260%
2/10/2022	Citigroup Inc.	98,738	$2.28M	0.0%	+83.2%	0.218%
2/10/2022	HighTower Advisors LLC	24,880	$0.58M	0.0%	N/A	0.055%
2/9/2022	Principal Financial Group Inc.	596,962	$13.79M	0.0%	+21.8%	1.315%
2/9/2022	Evoke Wealth LLC	31,914	$0.74M	0.0%	N/A	0.070%
2/8/2022	Jennison Associates LLC	514,978	$11.90M	0.0%	+45.5%	1.135%
2/8/2022	ProShare Advisors LLC	12,120	$0.28M	0.0%	N/A	0.027%
2/8/2022	Northern Trust Corp	249,293	$5.76M	0.0%	-1.5%	0.549%
2/7/2022	Victory Capital Management Inc.	1,032,278	$23.85M	0.0%	-1.8%	2.275%
2/7/2022	SG Americas Securities LLC	91,464	$2.11M	0.0%	+848.6%	0.202%
2/3/2022	OUP Management Co. LLC	989,232	$22.85M	10.3%	N/A	2.180%
2/2/2022	DekaBank Deutsche Girozentrale	16,000	$0.38M	0.0%	N/A	0.035%
2/1/2022	Zurcher Kantonalbank Zurich Cantonalbank	2,022	$47K	0.0%	N/A	0.004%
2/1/2022	Assenagon Asset Management S.A.	105,084	$2.43M	0.0%	+84.5%	0.232%
2/1/2022	Qube Research & Technologies Ltd	18,168	$0.42M	0.0%	N/A	0.040%
1/25/2022	Interwest Venture Management Co.	3,234,911	$74.73M	44.2%	-16.4%	7.128%
1/19/2022	Asymmetry Capital Management L.P.	97,680	$2.26M	1.2%	-3.2%	0.215%
12/14/2021	UBS Asset Management Americas Inc.	186,162	$5.55M	0.0%	-2.9%	0.410%
12/3/2021	Perceptive Advisors LLC	301,714	$8.99M	0.1%	-59.6%	0.665%
11/18/2021	Personal CFO Solutions LLC	355,342	$10.59M	2.2%	-7.8%	0.783%
11/17/2021	ArrowMark Colorado Holdings LLC	527,420	$15.72M	0.1%	+21.8%	1.162%
11/16/2021	Two Sigma Investments LP	14,500	$0.43M	0.0%	N/A	0.032%
11/16/2021	Voloridge Investment Management LLC	54,417	$1.62M	0.0%	+409.6%	0.120%
11/15/2021	Cubist Systematic Strategies LLC	39,751	$1.19M	0.0%	+242.7%	0.088%
11/15/2021	California State Teachers Retirement System	23,362	$0.70M	0.0%	-35.4%	0.052%
11/15/2021	RTW Investments LP	809,863	$24.13M	0.4%	+67.3%	1.788%
11/15/2021	Marshall Wace LLP	12,716	$0.38M	0.0%	N/A	0.028%
11/15/2021	Sphera Funds Management LTD.	190,525	$5.68M	0.5%	+126.6%	0.421%
11/15/2021	Atom Investors LP	27,199	$0.81M	0.1%	-70.8%	0.060%
11/15/2021	Invesco Ltd.	172,726	$5.15M	0.0%	-20.5%	0.381%
11/15/2021	HighVista Strategies LLC	39,777	$1.19M	0.8%	+67.4%	0.088%
11/15/2021	Hershey Trust Co.	3,582	$0.11M	0.0%	-53.4%	0.008%
11/12/2021	The Manufacturers Life Insurance Company	13,750	$0.41M	0.0%	-6.3%	0.030%
11/12/2021	Geode Capital Management LLC	433,473	$12.92M	0.0%	+24.5%	0.957%
11/10/2021	Goldman Sachs Group Inc.	293,840	$8.76M	0.0%	+89.1%	0.649%
11/10/2021	Rafferty Asset Management LLC	79,449	$2.37M	0.0%	+128.9%	0.175%
11/10/2021	Alliancebernstein L.P.	13,200	$0.39M	0.0%	-32.0%	0.029%
11/9/2021	BlackRock Inc.	2,187,923	$65.20M	0.0%	+14.1%	4.831%
11/9/2021	Jennison Associates LLC	354,049	$10.55M	0.0%	-1.1%	0.782%
11/9/2021	Principal Financial Group Inc.	489,935	$14.60M	0.0%	+6.1%	1.082%
11/9/2021	TD Asset Management Inc.	17,600	$0.52M	0.0%	-6.4%	0.039%
11/8/2021	Los Angeles Capital Management LLC	12,550	$0.37M	0.0%	N/A	0.028%
11/4/2021	Asymmetry Capital Management L.P.	100,882	$3.01M	1.8%	-0.9%	0.223%
11/4/2021	Deutsche Bank AG	59,246	$1.77M	0.0%	-0.8%	0.131%
11/2/2021	New York State Common Retirement Fund	18,973	$0.57M	0.0%	-16.1%	0.042%

Data available starting January 2016

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Today's Range

Now: $17.17

$16.12

$17.27

50 Day Range

MA: $13.83

$9.23

$17.12

52 Week Range

Now: $17.17

$8.99

$35.75

Volume

28,204 shs

Average Volume

1,154,499 shs

Market Capitalization

$782.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14

Who are the company insiders with the largest holdings of PMV Pharmaceuticals?: PMV Pharmaceuticals' top insider investors include:
Arnold J Levine (Director)
Arnold J Levine (Director)
Orbimed Advisors Llc (Major Shareholder)
David Henry Mack (CEO)
Winston Kung (CFO)
Leila Alland (Insider)
Euclidean Capital Llc (Major Shareholder)
Laszlo Kopits (General Counsel)
Ling Zang (Director)
Paul Klauder (EVP)
Ra Capital Management, LP (Major Shareholder)
Richard A Heyman (Director)
Thilo Schroeder (Director)
Learn More about top insider investors at PMV Pharmaceuticals.
Who are the major institutional investors of PMV Pharmaceuticals?: PMV Pharmaceuticals' top institutional shareholders include:
Interwest Venture Management Co. — 3.54%
Assenagon Asset Management S.A. — 1.38%
Personal CFO Solutions LLC — 1.21%
Evoke Wealth LLC — 0.29%
SG Americas Securities LLC — 0.14%
Swiss National Bank — 0.11%
Learn More about top institutional investors of PMV Pharmaceuticals stock.
Which major investors are selling PMV Pharmaceuticals stock?: Within the previous quarter, PMVP stock was sold by these institutional investors:
Interwest Venture Management Co.
Belvedere Trading LLC
Assenagon Asset Management S.A.
Within the last year, company insiders that have sold PMV Pharmaceuticals company stock include:
Arnold J Levine (Director)
Arnold J Levine (Director)
Orbimed Advisors Llc (Major Shareholder)
David Henry Mack (CEO)
Winston Kung (CFO)
Learn More investors selling PMV Pharmaceuticals stock.
Which major investors are buying PMV Pharmaceuticals stock?: In the previous quarter, PMVP stock was purchased by institutional investors including:
Personal CFO Solutions LLC
Evoke Wealth LLC
SG Americas Securities LLC
M&T Bank Corp
Swiss National Bank
Los Angeles Capital Management LLC
Russell Investments Group Ltd.
Simplex Trading LLC